Holen Sie sich die Stockscreener-App
18.44
1.86%
-0.35
Handel nachbörslich:
18.44
Finanzdaten der Urogen Pharma Ltd-Aktie (URGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
37.68%
37.84
|
27.48 | 24.21 | 20.25 | 24.57 |
| Cost Of Revenue |
0.34%
3.289
|
3.278 | 3.55 | 2.33 | 2.471 |
| Gross Profit |
42.74%
34.55
|
24.20 | 20.66 | 17.92 | 22.09 |
Operating Expenses
|
4.02%
53.66
|
51.59 | 62.11 | 54.84 | 49.75 |
| Benefits Costs and Expenses |
4.19%
64.48
|
61.88 | 73.14 | 63.70 | - |
| Costs And Expenses |
4.19%
64.48
|
61.88 | 73.14 | 63.70 | - |
| Operating Income/Loss |
30.20%
-19.11
|
-27.39 | -41.45 | -36.91 | -27.66 |
| Nonoperating Income/Loss |
97.46%
-0.005
|
-0.197 | -0.378 | -0.09 | -0.062 |
| Income/Loss From Continuing Operations Before Tax |
22.56%
-26.64
|
-34.40 | -48.92 | -43.45 | 24.57 |
| Income Tax Expense/Benefit |
73.91%
-0.275
|
-1.054 | 1.015 | 0.392 | 2.649 |
| Income/Loss From Continuing Operations After Tax |
20.94%
-26.36
|
-33.35 | -49.94 | -43.84 | -37.51 |
|
Net Income/Loss
|
20.94%
-26.36
|
-33.35 | -49.94 | -43.84 | -37.51 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.22%
0.3738
|
48.06 | 47.74 | 47.42 | 47.03 |
| Basic Earnings Per Share |
23.19%
-0.53
|
-0.69 | -1.05 | -0.92 | -0.80 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):